Sunday, October 10, 2010 8:49:17 AM
One thing that bothered me with regards to the EAGLE trial was that only 2 sites were located in the US (see slide below). I asked the CEO at the time (Dr. Laster) and the reason he gave was as expected - cost. However, he also told me later that the data were similar in terms of response, efficacy and AE for different sites and historical data of Risperidone.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
